Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Operating Income (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) recorded Operating Income of $39.73 million in Q2 2026, down 5.8% from $42.18 million a year earlier but up 191.5% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Operating Income (2013 - 2026) Analysis & Trends

On a TTM basis, Amphastar Pharmaceuticals' Operating Income came in at $114.29 million as of Jun 30, 2026, down 37.1% year-over-year; for FY2025, it was $140.4 million, down 31.7% from FY2024.

  • Annual Operating Income has a five-year compound annual growth rate of 66.6% (FY2020 to FY2025).
  • Across earlier years, Operating Income came in at $205.42 million in FY2024 (+4.3%), $196.99 million in FY2023 (+83.2%), $107.5 million in FY2022 (+53.8%) and $69.89 million in FY2021 (+538.0%).
  • Quarterly Operating Income has ranged from $13.63 million in Q1 2026 to $72.68 million in Q3 2023 over the past five years.
  • On a year-over-year basis, Operating Income has declined for eight consecutive quarters, with an average decline of 28.7% over the last eight quarters.
  • Peak year-over-year performance for Operating Income in the last five years was growth of 742.4% in Q4 2021, against a decline of 63.5% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $13.63 million (Q1 2026), $35.61 million (Q4 2025) and $25.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn 39.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.73 Mn
Mar 31, 2026 13.63 Mn
Dec 31, 2025 35.61 Mn
Sep 30, 2025 25.32 Mn
Jun 30, 2025 42.18 Mn
Mar 31, 2025 37.29 Mn
Dec 31, 2024 45.14 Mn
Sep 30, 2024 57.05 Mn
Jun 30, 2024 55.22 Mn
Mar 31, 2024 48.01 Mn
Dec 31, 2023 53.98 Mn
Sep 30, 2023 72.68 Mn
Jun 30, 2023 36.90 Mn
Mar 31, 2023 33.43 Mn
Dec 31, 2022 37.83 Mn
Sep 30, 2022 23.23 Mn
Jun 30, 2022 24.82 Mn
Mar 31, 2022 21.61 Mn
Dec 31, 2021 24.25 Mn
Sep 30, 2021 24.77 Mn
API Access

Amphastar Pharmaceuticals Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=AMPH&period=max&api_key=YOUR_API_KEY